Securities Code: 300723
Securities Abbreviation: Yipinhong
Announcement Number: 2026-027
Announcement on the Launch of Foreign Exchange Derivative Hedging Business
The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Important Content Reminder:
- In order to effectively avoid risks from RMB exchange rate fluctuations and enhance the company's ability to withstand exchange rate volatility, Yipinhong Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") and its subsidiaries plan to conduct foreign exchange derivative hedging activities at banks and other financial institutions, with an amount not exceeding USD 10 million. This includes but is not limited to forward foreign exchange contracts, foreign exchange swaps, foreign exchange options, and combinations of the aforementioned products.
- This matter has been reviewed and approved by the 18th meeting of the 4th board of directors and does not require submission to the shareholders' meeting for approval.
- The Company will conduct foreign exchange derivative transactions following the principle of locking in exchange rate risks and will not engage in speculative or arbitrage trading operations. However, there are still risks associated with foreign exchange derivative hedging, including exchange rate fluctuation risks, internal control risks, customer default risks, or collection forecast risks, and other risks. Investors are advised to pay attention to investment risks.